The Effect of Motivational Interviewing on the Adherence to Medication of Patients With COVID-19 Diagnosed at Home (MOTIVATION)
Drug Compliance
About this trial
This is an interventional supportive care trial for Drug Compliance focused on measuring COVID-19, Medication Compliance, Motivational Interviewing, Health Education
Eligibility Criteria
Inclusion Criteria: Those who volunteered to participate in the study 18 years old and over, Able to read and write Turkish, Having a COVID-19 patient followed at home, Having the equipment to make video calls over the internet connection, Individuals with a drug compliance reporting scale score below 20 points Exclusion Criteria: Contraindicated to use antiviral drug (Favipiravir) (liver failure, kidney failure, active chemotherapy treatment) Pregnant, Patients who were hospitalized for any reason during the study
Sites / Locations
- University of Health Sciences
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
intervention group
control group
On the second day of the COVID-19 antiviral drug treatment, the participant assigned to the intervention group was interviewed face-to-face during the home visit by providing isolation measures. In the face-to-face meeting, the "COVID-19 Medication Use Brochure" was given and it was stated that the participants would be video-talked about the topics included in the booklet at an appropriate time on the same day, and time was planned. In the interview, it was decided to allow the participant to tell about their antiviral drug use, to learn about their feelings, thoughts and behaviors about drug use, to reveal their feelings of indecision and anxiety about treatment, to determine their resistance to drug use, to reveal their intrinsic motivation, to support them and to change their behavior. It was intended to take action to advance the cycle of change.
After randomization, the participants in the control group continued to receive health care according to the standard COVID-19 drug treatment procedures determined by the Ministry of Health. No other intervention was performed apart from the participant standard COVID-19 drug therapy procedures in the control group.